Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
169 - 180 of 185 Results
Sort by:
Best Match
Whitepaper
Practical cell counting method selection to increase the quality of results based on ISO cell counting standards
White paper describing best practices for the selection of a fit-for-purpose cell counting method to improve the quality of results.
Brochure
Celigo image cytometer whole well imaging
Brochure describing the Celigo image cytometer.
Flyer
Cell-based screening on the Celigo image cytometer
Flyer describing the benefits of cell-based screening on the Celigo image cytometer.
Brochure
Automated cell counting and image cytometry solutions brochure
Brochure showing Revvity's automated cell counting and image cytometry instruments, consumables and reagents.
Scientific Poster
Automated high-throughput method for assessing pathogenic infectious dose (TCID50) using Celigo imaging cytometer
Automated high-throughput method for assessing pathogenic infectious dose (TCID50) using Celigo imaging cytometer
Guide
The issue of CHO HCPs during biopharmaceutical production
Detecting and quantifying CHO HCPs with automatable homogeneous immunoassays
Application Note
Advantages of using our automatable and no-wash HTRF and AlphaLISA kits for CHO HCP detection
Read this application note to learn about CHO HCP impurity quantification using AlphaLISA and HTRF technologies
Flyer
Advance your biologics research with Revvity solutions
Revvity’s no-wash tools empower biotherapeutics research—from screening to biomanufacturing. Discover precision and efficiency.
Infographic
Safety rules with Revvity biotherapeutic workflows
Improve safety and efficacy of your GMP manufacturing workflows with this infographic exploring Revvity instruments, reagents and assays.
Flyer
Host cell contamination detection flyer
Be safe in quantifying residual host cell DNA and proteins when developing your next biologic, cell or gene therapy.
Literature - Publication Review
Current approaches to identify possible COVID-19 therapeutics
Current approaches to identify possible COVID-19 treatment strategies fall into one of three categories: Antivirals, antibodies, or protein-protein interaction inhibitors.
Whitepaper
An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.